BioMed Central home | Journals A-Z | Feedback | My details

Open AccessResearch

Depression in mothers of children with thalassemia or blood malignancies: a study from Iran

Afshan Sharghi1, Mojgan Karbakhsh2, Behrooz Nabaei3, Alipasha Meysamie2 and AliReza Farrokhi4

Department of Community Medicine, Ardebil University of Medical Sciences, Daneshgah Ave, Ardebil, Iran

Department of Community Medicine, Tehran University of Medical Sciences, Poursina st, Qods st, Enqelab st, Tehran, Iran

Department of Community Medicine, Tehran University of Medical Sciences, Poursina st, Qods st, Enqelab st, Tehran, Iran

Legal Medicine Center of Ardebil Province, Panzdah Khordad Square, Ardebil, Iran

Clinical Practice and Epidemiology in Mental Health 2006, 2:27doi:10.1186/1745-0179-2-27

Published: 4 October 2006

Abstract

Background

Several studies have found that parents of children with chronic diseases or disabilities have higher depression scores than control parents. Mothers usually take on the considerable part of the extra care and support that these children need and thus are at markedly increased risks of suffering from psychological distress and depression. The main aim of the present study was to investigate if mothers of children with thalassemia or blood malignancies have higher scores of depression compared with a group of control mothers.

Methods and materials

In this cross – sectional study, 294 mothers were recruited in three groups and assessed using the Beck Depression Inventory (BDI): mothers of children with thalassemia, mothers of children with blood malignancies and a control group. SPSS version 11.5 with chi square, ANOVA, linear and logistic regression were used for statistical analysis.

Results

The only variable bearing a statistically significant relationship with the depression score of mothers was the child's disease: for thalassemia with OR of 2.17 (95% CI = 1.16–4.0, P = 0.015), for blood malignancies with OR of 2.71 (95% CI = 1.48–4.99, P = 0.001).

Discussion and conclusion

The results of this study can contribute to the development of a screening program for decreasing depression burden and promoting quality of life for mothers of children with thalassemia or blood malignancies.


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.